Guru Ownership Trend
Guru Analysis for Candel Therapeutics, Inc. (CADL)
Candel Therapeutics, Inc. (CADL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.37 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $676,294 net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Candel Therapeutics, Inc. (CADL)
Major holders include Steven Cohen ($525,334), Cliff Asness ($88,338), Renaissance Technologies (RenTech) ($62,622). According to the latest reported data, 3 tracked investment managers collectively hold approximately 138,019 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $676,294, with 3 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in CADL during the most recent reporting period.
Yes, 3 managers opened new positions in CADL, and 0 increased their existing holdings. The total reported buy value was $676,294.